Review
BibTex RIS Cite

Pediatrik metabolik hastalıklarda kardiyovasküler bulgular

Year 2019, Volume: 12 Issue: 2, 357 - 366, 28.05.2019
https://doi.org/10.31362/patd.518230

Abstract

Kardiyak bulgular pediatrik metabolik
hastalıkların birçoğuna eşlik eden önemli bir klinik sorundur. Hatta bazı
metabolik hastalıklarda hastalığın ilk klinik bulgusu kardiyak bulgular olabilir.
Kardiyak bulgular hastalığın seyrinde morbidite ve mortalitede önemli artışa
neden olmaktadır. Kardiyomiyopati metabolik hastalıklarda en sık görülen
kardiyak problemdir. Bununla birlikte, mitokondriyal bozukluklar ve organik
asidemilerde aritmiler, depo hastalıkarında ise kapak tutulumu  daha belirgin bulgudur. Bu hastalıkların
erken tanı ve tedavisi ile kardiyovasküler sorunlar da önemli bir oranda
azalacaktır. Bu nedenle, metabolik hastalıklı çocukların takiplerinde kardiyak
tutulum açısından mutlaka sistematik tarama yapılmalıdır.

References

  • Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 2000;105:e10.
  • Wicks EC, Elliott PM. Genetics and metabolic cardiomyopathies. Herz 2012;37:598-610.

Cardiovascular findings in pediatric metabolic diseases

Year 2019, Volume: 12 Issue: 2, 357 - 366, 28.05.2019
https://doi.org/10.31362/patd.518230

Abstract

Cardiac findings is an important clinical problem
associated with many pediatric metabolic diseases. Even, cardiac findings may
be first clinical manifestation of the disease in some metabolic diseases.
Cardiac findings causes a significant increase in morbidity and mortality in
the course of the disease. Cardiomyopathy is the most common cardiac problem in
most metabolic diseases. However, arrhythmias are commonly seen in
mitochondrial disorders and organic acidemias, while valve involvement is the
most predominat finding in storage diseases. With the early diagnosis and treatment
of these diseases, the cardiovascular problems will be reduced significantly. Therefore,
in the follow-up of children with metabolic disease, systematic screening
should be performed for cardiac involvement.

References

  • Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 2000;105:e10.
  • Wicks EC, Elliott PM. Genetics and metabolic cardiomyopathies. Herz 2012;37:598-610.
There are 2 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Collection
Authors

Özlem Elkıran 0000-0002-6855-0346

Publication Date May 28, 2019
Submission Date January 26, 2019
Acceptance Date May 15, 2019
Published in Issue Year 2019 Volume: 12 Issue: 2

Cite

APA Elkıran, Ö. (2019). Pediatrik metabolik hastalıklarda kardiyovasküler bulgular. Pamukkale Medical Journal, 12(2), 357-366. https://doi.org/10.31362/patd.518230
AMA Elkıran Ö. Pediatrik metabolik hastalıklarda kardiyovasküler bulgular. Pam Med J. May 2019;12(2):357-366. doi:10.31362/patd.518230
Chicago Elkıran, Özlem. “Pediatrik Metabolik hastalıklarda kardiyovasküler Bulgular”. Pamukkale Medical Journal 12, no. 2 (May 2019): 357-66. https://doi.org/10.31362/patd.518230.
EndNote Elkıran Ö (May 1, 2019) Pediatrik metabolik hastalıklarda kardiyovasküler bulgular. Pamukkale Medical Journal 12 2 357–366.
IEEE Ö. Elkıran, “Pediatrik metabolik hastalıklarda kardiyovasküler bulgular”, Pam Med J, vol. 12, no. 2, pp. 357–366, 2019, doi: 10.31362/patd.518230.
ISNAD Elkıran, Özlem. “Pediatrik Metabolik hastalıklarda kardiyovasküler Bulgular”. Pamukkale Medical Journal 12/2 (May 2019), 357-366. https://doi.org/10.31362/patd.518230.
JAMA Elkıran Ö. Pediatrik metabolik hastalıklarda kardiyovasküler bulgular. Pam Med J. 2019;12:357–366.
MLA Elkıran, Özlem. “Pediatrik Metabolik hastalıklarda kardiyovasküler Bulgular”. Pamukkale Medical Journal, vol. 12, no. 2, 2019, pp. 357-66, doi:10.31362/patd.518230.
Vancouver Elkıran Ö. Pediatrik metabolik hastalıklarda kardiyovasküler bulgular. Pam Med J. 2019;12(2):357-66.

Creative Commons Lisansı
Pamukkale Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License